FTRE
Fortrea Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$19.93
−1.73%Forward multiples
Based on analyst estimates
- P/E forward
- 21.06x
- P/E 2026E
- 23.29x
- P/E 2027E
- 18.40x
- P/E 2028E
- 14.69x
- P/S forward
- 0.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.62x
- Price / sales
- 0.71x
- Price / cash flow
- 10.39x
Enterprise value
- Enterprise value
- $2.8B
- EV / sales
- 1.06x
- EV / EBITDA
- 35.03x
- EV / EBIT
- 258.57x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026